uniQure N.V. Quarterly Cash Flow Statement
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 22.72 +0.58%
uniQure N.V. free cash flow
In the quarter ended Mar 31, 2026, uniQure N.V. generated -$38.2 million of operating cash flow and spent $140,000 on capital expenditures. That left free cash flow of -$38.4 million, a free-cash-flow margin of -1077.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
uniQure N.V. cash flow statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -53.53M | -37.09M | -80.53M | -37.72M | -43.64M | -73.26M | -44.38M | -56.30M | -65.62M | -73.21M | -89.57M | -68.47M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | -1175.45% | — | — |
| Depreciation & Amortization | 2.96M | 2.97M | 3.63M | 3.63M | 4.53M | 4.36M | 2.99M | 2.67M | 2.63M | 4.19M | 2.60M | 2.59M |
| Stock-Based Compensation | 5.09M | 4.66M | 3.52M | 5.08M | 4.41M | 4.75M | 3.44M | 6.88M | 7.19M | 7.04M | 11.10M | 8.89M |
| Change in Working Capital | -557.00K | -1.02M | 649.00K | -204.00K | -2.09M | 8.33M | -163.00K | -5.76M | 1.53M | 2.60M | -9.01M | -2.29M |
| Operating Cash Flow | -38.24M | -77.57M | -16.40M | -39.90M | -44.10M | -52.84M | -36.60M | -32.71M | -60.58M | -49.54M | 38.91M | -57.00M |
| Capital Expenditures | -140.00K | -119.00K | 66.00K | -260.00K | -126.00K | -40.00K | -380.00K | -604.00K | -2.34M | -2.04M | -1.70M | -1.07M |
| Investing Cash Flow | 98.56M | -441.37M | 26.58M | 73.07M | 20.10M | -26.62M | 47.67M | 77.94M | 63.98M | 59.56M | -314.07M | 45.83M |
| Debt Repaid | — | — | — | — | — | 0 | — | — | — | — | — | — |
| Financing Cash Flow | 550.00K | 2.45M | 332.24M | 44.00K | 80.67M | -6.52M | -53.02M | — | — | 46.00K | -7.59M | 370.14M |
| Net Change in Cash | 59.73M | -516.75M | 343.28M | 36.61M | 58.33M | -92.75M | -37.96M | 44.81M | 1.69M | 11.91M | -284.14M | 359.75M |
| Free Cash Flow | -38.38M | -77.69M | -16.33M | -40.16M | -44.23M | -52.88M | -36.98M | -33.31M | -62.92M | -51.58M | 37.21M | -58.07M |
This table shows 12 quarterly periods of uniQure N.V.'s cash flow statement, from Q1 2026 back to Q2 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow QURE's reporting calendar. What is a cash flow statement?